INS and diabetes mellitus: To achieve this aim, three distinct protocols were applied and assessed using in vitro parameters particularly insulin related genes and insulin release assay to nominate the most promising protocol to be applied in in vivo study to evaluate the efficacy of IPCs generated from the durable protocol as cell-based therapy for DM using STZ diabetic rat model.